<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-88889" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Advancing Wavelike Epitheliopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moshirfar</surname>
            <given-names>Majid</given-names>
          </name>
          <aff>University of Utah/John Moran Eye Center; Hoopes Vision/HDR Research Center; Utah Lions Eye Bank</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>West</surname>
            <given-names>William</given-names>
          </name>
          <aff>University of Utah School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ronquillo</surname>
            <given-names>Yasmyne</given-names>
          </name>
          <aff>Hoopes Vision Research Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Majid Moshirfar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>William West declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasmyne Ronquillo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>18</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-88889.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Advancing wavelike epitheliopathy (AWE) is a chronic or recurrent disorder characterized by well-demarcated, wavelike plaques of coarse, thickened corneal epithelium. This activity reviews the etiology, epidemiology, and pathophysiology of advancing wavelike epitheliopathy. It also summarizes current recommendations on the evaluation, treatment, and management of patients with this condition. It discusses the role of the interprofessional team.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of advancing wavelike epitheliopathy.</p></list-item><list-item><p>Explain the common ocular exam findings associated with advancing wavelike epitheliopathy.</p></list-item><list-item><p>Identify the treatment considerations for patients with advancing wavelike epitheliopathy.</p></list-item><list-item><p>Explain the importance of improving care coordination amongst the interprofessional team to enhance the delivery of care for patients with advancing wavelike epitheliopathy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=88889&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=88889">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-88889.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Advancing wavelike epitheliopathy (AWE) is a chronic or recurrent disorder characterized by well-demarcated, wavelike plaques of coarse, thickened corneal epithelium. This process characteristically extends from the superior limbus and spreads toward the visual axis.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref> Some cases also show that they may originate from the inferior limbus.<xref ref-type="bibr" rid="article-88889.r2">[2]</xref> Corneal epithelial scrapings show no signs of dysplasia or irregularity, and the conjunctiva remains unaffected.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref> AWE can be unilateral or bilateral.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref></p>
      </sec>
      <sec id="article-88889.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>While the exact cause of&#x000a0;advancing wavelike epitheliopathy remains unclear, it appears that it may occur in response to irritation or insult to the corneal epithelium. Possible stimuli include prior ocular surgery, contact lens use, topical ocular medications, ocular exposure to toxins or irritants, or underlying inflammatory or dermatological disorders.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref><xref ref-type="bibr" rid="article-88889.r3">[3]</xref><xref ref-type="bibr" rid="article-88889.r4">[4]</xref></p>
        <p>Specific possible medications include:<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Topical antiglaucoma medications</p>
          </list-item>
          <list-item>
            <p>5-fluorouracil</p>
          </list-item>
          <list-item>
            <p>Topical acyclovir</p>
          </list-item>
          <list-item>
            <p>Contact lens solution</p>
          </list-item>
        </list>
        <p>Specific possible disease processes include:<xref ref-type="bibr" rid="article-88889.r1">[1]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Ocular cicatricial pemphigoid</p>
          </list-item>
          <list-item>
            <p>Acne rosacea</p>
          </list-item>
          <list-item>
            <p>Atopic dermatitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-88889.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Advancing wavelike epitheliopathy usually presents after the age of 40, can be monocular or binocular, and occurs equally in males and females.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref><xref ref-type="bibr" rid="article-88889.r5">[5]</xref></p>
      </sec>
      <sec id="article-88889.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Very little is known about the underlying mechanism of advancing wavelike epitheliopathy, which appears to be multifactorial. D&#x02019;Aversa et al., the first to report on this disease, suggest that it may stem from abnormal parakeratotic limbal epithelial stem cells proliferating and migrating onto the cornea, leading to the characteristic epithelial waves.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref> This process presents similarly to partial limbal stem cell deficiency or dysfunction, which lends credence to the theory that these may arise from similar disease processes. Patients with limbal stem cell deficiency (LCSD) also present with symptoms of blurry vision and corneal irritation.<xref ref-type="bibr" rid="article-88889.r6">[6]</xref> LCSD often exhibits epitheliopathy arising from the involved limbus, most commonly at the superior limbus, as does AWE.<xref ref-type="bibr" rid="article-88889.r7">[7]</xref><xref ref-type="bibr" rid="article-88889.r8">[8]</xref><xref ref-type="bibr" rid="article-88889.r9">[9]</xref>&#x000a0;LCSD may occur through similar stimuli, including trauma, surgery, contact lens use, and topical antiglaucoma medications.<xref ref-type="bibr" rid="article-88889.r6">[6]</xref><xref ref-type="bibr" rid="article-88889.r7">[7]</xref><xref ref-type="bibr" rid="article-88889.r8">[8]</xref><xref ref-type="bibr" rid="article-88889.r9">[9]</xref><xref ref-type="bibr" rid="article-88889.r10">[10]</xref><xref ref-type="bibr" rid="article-88889.r11">[11]</xref></p>
      </sec>
      <sec id="article-88889.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Pathology shows unremarkable epithelium on H&#x00026;E staining. Epithelial dysplasia is not present on the histological exam of the debrided epithelium.<xref ref-type="bibr" rid="article-88889.r2">[2]</xref><xref ref-type="bibr" rid="article-88889.r5">[5]</xref><xref ref-type="bibr" rid="article-88889.r1">[1]</xref> Full-thickness biopsy shows parakeratosis of the conjunctival epithelium and underlying focal mononuclear cell infiltrates, which may compress or extend into the overlying epithelium.<xref ref-type="bibr" rid="article-88889.r5">[5]</xref> One study showed a reduction in the subepithelial nerve plexus compared to healthy eyes.<xref ref-type="bibr" rid="article-88889.r4">[4]</xref></p>
      </sec>
      <sec id="article-88889.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with AWE present with decreased visual acuity, which chronically progresses or relapses and with periods of remission over months to years. Patients also complain of foreign body sensation, tearing, redness, or irritation, although some may be asymptomatic if the lesion is small and outside the visual axis. History of ocular surgery or trauma, topical ocular medications, atopic dermatitis, or acne rosacea have all been associated with the disease process.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r5">[5]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref></p>
        <p>The slit-lamp exam with fluorescein staining along with confocal microscopy are tools for diagnosis and show specific findings as described below.</p>
      </sec>
      <sec id="article-88889.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of advancing wavelike epitheliopathy is made clinically with the use of a slit lamp and confocal microscopy. Slit-lamp examination reveals a well-demarcated, wavelike plaque progressing from the superior limbus. Sclerotic scatter reveals a granular texture and distinct lesion margins (Figure 1).<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref>&#x000a0;A subepithelial haze may be present with no discrete opacities or infiltrates within the patches (Figure 2). Fluorescein staining shows a punctate pattern with well-defined borders.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref><xref ref-type="bibr" rid="article-88889.r5">[5]</xref> Confocal microscopy shows atypical, elongated cells oriented centripetally with hyperreflective nuclei, a large nuclear to cytoplasmic ratio, and loss of visible cellular borders in the basal epithelium.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref></p>
      </sec>
      <sec id="article-88889.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The accepted course of treatment for advancing wavelike epitheliopathy is the elimination of identifiable offending agents, debridement of the abnormal epithelium, and empiric application of a 1% silver nitrate solution to the superior corneoscleral limbus.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r5">[5]</xref>&#x000a0;</p>
        <p>Most sterile compounding pharmacies are able to formulate this solution, as it is not available in a premade form. For treatment, the affected eye should be anesthetized with proparacaine, after which a cotton applicator is saturated with 1% silver nitrate solution and applied in a rolling fashion to the affected area. The area is flushed with saline, a bandage contact lens applied, and a 1-week course of topical antibiotics is prescribed. The bandage lens may be removed after 3 to 4 days, after complete epithelialization for the cornea.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r5">[5]</xref></p>
        <p>Symptoms usually resolve within two weeks of treatment with the replacement of irregular epithelium with normal-appearing tissue. Following treatment, most patients experience a total return of vision in the affected eye, although some patients exhibit a mild permanent decrease in visual acuity.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref><xref ref-type="bibr" rid="article-88889.r5">[5]</xref> In cases where AWE does not cause symptoms, simply removing the causative agent may be sufficient for resolution.</p>
        <p>Silver nitrate likely works via its cytological effects, causing apoptosis or chemical alteration of the abnormal stem cells that are responsible for the pathology.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref> One study used liquid nitrogen cryotherapy in place of silver nitrate with similar results.<xref ref-type="bibr" rid="article-88889.r5">[5]</xref></p>
        <p>Corneal epithelial debridement allows for a more complete treatment of the epitheliopathy and a more rapid resolution of symptoms.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref> Debridement alone is temporarily adequate but is almost universally followed by recurrence and the need for repeat treatment after several months.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref> One theory suggests that abnormal limbal stem cells may be the source of the pathology and must be altered to obtain complete resolution. Silver nitrate and cryotherapy appear to fill this role.<xref ref-type="bibr" rid="article-88889.r2">[2]</xref><xref ref-type="bibr" rid="article-88889.r7">[7]</xref></p>
        <p>AWE has rarely responded to artificial tears and topical steroids, although most patients showed no improvement, and steroid use was discontinued in all cases due to a rise in intraocular pressure. Hypertonic saline solution, antibiotics, and therapeutic contact lenses have been found to have little or no benefit in treating AWE.<xref ref-type="bibr" rid="article-88889.r2">[2]</xref><xref ref-type="bibr" rid="article-88889.r1">[1]</xref></p>
        <p>Because of the similarities between AWE and partial limbal stem cell deficiency, there is the possibility that additional medical therapies effective in partial LCSD may also be applied to the treatment of AWE. These include topical retinoids, topical cyclosporine, autologous topical serum drops, and interferon-alpha-2b.<xref ref-type="bibr" rid="article-88889.r6">[6]</xref><xref ref-type="bibr" rid="article-88889.r7">[7]</xref><xref ref-type="bibr" rid="article-88889.r8">[8]</xref><xref ref-type="bibr" rid="article-88889.r12">[12]</xref><xref ref-type="bibr" rid="article-88889.r13">[13]</xref> These treatments have yet to be proven and will need clinical trials for validation.</p>
      </sec>
      <sec id="article-88889.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several ocular diseases can present similarly to advancing wavelike epitheliopathy but can be identified or ruled out based on physical exam findings and response to treatment. These conditions include the following:<xref ref-type="bibr" rid="article-88889.r1">[1]</xref><xref ref-type="bibr" rid="article-88889.r2">[2]</xref><xref ref-type="bibr" rid="article-88889.r5">[5]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Corneal intraepithelial neoplasia</p>
          </list-item>
          <list-item>
            <p>Corneal epithelial dysplasia</p>
          </list-item>
          <list-item>
            <p>Squamous cell carcinoma</p>
          </list-item>
          <list-item>
            <p>Carcinoma in situ</p>
          </list-item>
          <list-item>
            <p>Hereditary benign intraepithelial dyskeratosis</p>
          </list-item>
          <list-item>
            <p>Corneal pannus</p>
          </list-item>
          <list-item>
            <p>Corneal epithelial keratinization</p>
          </list-item>
          <list-item>
            <p>Contact lens-induced keratopathy</p>
          </list-item>
          <list-item>
            <p>Superior limbic keratoconjunctivitis</p>
          </list-item>
          <list-item>
            <p>Prominent epithelial basement membrane dystrophy</p>
          </list-item>
          <list-item>
            <p>Whorled microcystic dystrophy</p>
          </list-item>
          <list-item>
            <p>Underlying dermatologic or inflammatory disorders</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-88889.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The majority of cases respond well to silver nitrate resulting in a return of baseline vision, although rarely, patients may experience mild permanent vision loss. In some cases, small patches of irregular epithelium remain after treatment; however, remnants are almost exclusively at the corneal periphery, leaving the visual axis clear. Recurrence is rare and usually less severe, tending to occur outside the visual axis without requiring repeated treatment.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref></p>
      </sec>
      <sec id="article-88889.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications are rare but include corneal abrasion and incomplete resolution requiring further treatment.<xref ref-type="bibr" rid="article-88889.r1">[1]</xref></p>
      </sec>
      <sec id="article-88889.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients diagnosed with advancing wavelike epitheliopathy should seek to identify possible triggers and avoid those stimuli in the future. Patients who regularly wear contact lenses should be advised to maintain proper care of their lens and avoid extended wear. If a multipurpose contact lens solution is a possible cause, substitution with a hydrogen peroxide solution may be indicated.</p>
      </sec>
      <sec id="article-88889.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>AWE is a chronic or recurrent disorder characterized by progressive visual loss and often ocular irritation or discomfort.</p>
          </list-item>
          <list-item>
            <p>AWE usually occurs after the age of 40 and is more common in patients with a history of eye trauma or surgery, topical ocular medications, atopic dermatitis, and acne rosacea.</p>
          </list-item>
          <list-item>
            <p>AWE is diagnosed clinically with slit lamp and confocal microscopy. Pathology and confocal microscopy are also characteristic but not necessary for diagnosis.</p>
          </list-item>
          <list-item>
            <p>AWE is treated&#x000a0;with 1% silver nitrate applied topically and usually resolves within 2 to 3 weeks of a single treatment.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-88889.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients may approach primary care providers when initially experiencing the symptoms associated with AWE. Artificial tears may be beneficial for symptomatic relief of ocular irritation or discomfort. Patients who experience a confirmed decrease in visual acuity, use topical ocular medications, or have symptoms that do not resolve with conservative treatment should be referred to an ophthalmologist. Ophthalmology nurses and pharmacists aid in patient education and care. [Level 5]</p>
      </sec>
      <sec id="article-88889.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=88889&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=88889">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/advancing-wavelike-epitheliopathy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=88889">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/88889/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=88889">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-88889.s17">
        <fig id="article-88889.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Figure 1. Slit lamp image of Advancing Wavelike Epitheliopathy Contributed by Majid Moshirfar</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="11222019_20191209_113858_OS" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-88889.s18">
        <fig id="article-88889.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Figure 2. Image of Advancing Wavelike Epitheliopathy Contributed by Majid Moshirfar</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="11222019_20191227_132814_OS" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-88889.s19">
        <title>References</title>
        <ref id="article-88889.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Aversa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Luchs</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Udell</surname>
                <given-names>IJ</given-names>
              </name>
            </person-group>
            <article-title>Advancing wave-like epitheliopathy. Clinical features and treatment.</article-title>
            <source>Ophthalmology</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>104</volume>
            <issue>6</issue>
            <fpage>962</fpage>
            <page-range>962-9</page-range>
            <pub-id pub-id-type="pmid">9186437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Recurrent advancing wavelike epitheliopathy from the opposite side of the initial presentation.</article-title>
            <source>Cornea</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-3</page-range>
            <pub-id pub-id-type="pmid">18245978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Selvan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Markan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Holi colors and chemical contact keratitis.</article-title>
            <source>Eye (Lond)</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-3</page-range>
            <pub-id pub-id-type="pmid">29052605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Babu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Narasimha Murthy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ramachandra Murthy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Wavelike epitheliopathy after phacoemulsification: role of in vivo confocal microscopy.</article-title>
            <source>Cornea</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>747</fpage>
            <page-range>747-8</page-range>
            <pub-id pub-id-type="pmid">17592330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fraunfelder</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Liquid nitrogen cryotherapy of advancing wavelike epitheliopathy.</article-title>
            <source>Cornea</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-8</page-range>
            <pub-id pub-id-type="pmid">16371781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rossen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Amram</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Milani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Harthan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Joslin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McMahon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Djalilian</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Contact Lens-induced Limbal Stem Cell Deficiency.</article-title>
            <source>Ocul Surf</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>419</fpage>
            <page-range>419-434</page-range>
            <pub-id pub-id-type="pmid">27480488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Riaz</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Bakhtiari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Welder</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Basti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Djalilian</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Medically reversible limbal stem cell disease: clinical features and management strategies.</article-title>
            <source>Ophthalmology</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>121</volume>
            <issue>10</issue>
            <fpage>2053</fpage>
            <page-range>2053-8</page-range>
            <pub-id pub-id-type="pmid">24908203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sangwan</surname>
                <given-names>VS</given-names>
              </name>
            </person-group>
            <article-title>Limbal stem cells in health and disease.</article-title>
            <source>Biosci Rep</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>385</fpage>
            <page-range>385-405</page-range>
            <pub-id pub-id-type="pmid">11900318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeng</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Halfpenny</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Meisler</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Stock</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Management of focal limbal stem cell deficiency associated with soft contact lens wear.</article-title>
            <source>Cornea</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-23</page-range>
            <pub-id pub-id-type="pmid">20847651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dua</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Saini</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Azuara-Blanco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Limbal stem cell deficiency: concept, aetiology, clinical presentation, diagnosis and management.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>83</fpage>
            <page-range>83-92</page-range>
            <pub-id pub-id-type="pmid">11116520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sridhar</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Vemuganti</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Impression cytology-proven corneal stem cell deficiency in patients after surgeries involving the limbus.</article-title>
            <source>Cornea</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-8</page-range>
            <pub-id pub-id-type="pmid">11248816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tseng</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Maumenee</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Maumenee</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Kenyon</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Topical retinoid treatment for various dry-eye disorders.</article-title>
            <source>Ophthalmology</source>
            <year>1985</year>
            <month>Jun</month>
            <volume>92</volume>
            <issue>6</issue>
            <fpage>717</fpage>
            <page-range>717-27</page-range>
            <pub-id pub-id-type="pmid">3880512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-88889.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Tat</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Coroneo</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Treatment of partial limbal stem cell deficiency with topical interferon &#x003b1;-2b and retinoic acid.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>100</volume>
            <issue>7</issue>
            <fpage>944</fpage>
            <page-range>944-948</page-range>
            <pub-id pub-id-type="pmid">26508779</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
